We are live on ! Find out more
BIVV

Bioverativ Inc. Common Stock
BIVV

Delisted

BIVV was delisted on the 8th of March, 2018.

Back to rankings

2 hedge funds and large institutions have $27K invested in Bioverativ Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 449 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 459 → 2 (-457)

100% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 449

100% less funds holding in top 10

Funds holding in top 10: 5 → 0 (-5)

100% less capital invested

Capital invested by funds: $5.76B → $27K (-$5.76B)

Holders
2
Holders Change
-457
Holders Change %
-99.56%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
449
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ACS
Archford Capital Strategies
Illinois
+$2.28K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$585M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$497M
3
Primecap Management
Primecap Management
California
-$411M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$274M
5
State Street
State Street
Massachusetts
-$232M
Name Holding Trade Value Shares
Change 		Change in
Stake
WCM
351
Whitener Capital Management
North Carolina
– -$14K -265 Closed
HDIM
352
Hanson & Doremus Investment Management
Vermont
– -$14K -262 Closed
MM
353
Midas Management
New York
– -$13K -250 Closed
CBT
354
Central Bank & Trust
Kentucky
– -$13K -249 Closed
HNB
355
Huntington National Bank
Ohio
– -$13K -245 Closed
CTC
356
Central Trust Company
Missouri
– -$13K -237 Closed
CFA
357
Carroll Financial Associates
North Carolina
– -$12K -230 Closed
QCG
358
Quadrant Capital Group
Ohio
– -$7K -229 Closed
MFW
359
Mosaic Family Wealth
Missouri
– -$12K -227 Closed
AIM
360
Advantage Investment Management
Iowa
– -$11K -200 Closed
PCTC
361
Perkins Coie Trust Company
Washington
– -$11K -200 Closed
PMFA
362
Plante Moran Financial Advisors
Michigan
– -$11K -200 Closed
TG
363
TLP Group
Illinois
– -$11K -197 Closed
PG
364
Patten Group
Tennessee
– -$10K -194 Closed
FWM
365
Focused Wealth Management
New York
– -$10K -187 Closed
KF
366
Krilogy Financial
Missouri
– -$10K -186 Closed
GTAM
367
Global Trust Asset Management
Florida
– -$10K -179 Closed
KJWM
368
Kiley Juergens Wealth Management
Washington
– -$8K -159 Closed
PCP
369
Proficio Capital Partners
Massachusetts
– -$9K -158 Closed
TSW
370
Thompson Siegel & Walmsley
Virginia
– -$8K -150 Closed
AF
371
Advisornet Financial
Minnesota
– -$7K -139 Closed
CHP
372
Cable Hill Partners
Oregon
– -$8K -137 Closed
CHC
373
City Holding Co
West Virginia
– -$7K -137 Closed
QAM
374
QCI Asset Management
New York
– -$7K -130 Closed
VCM
375
Versant Capital Management
Arizona
– -$6K -117 Closed
13 14
15
16 17

BIVV Hedge Fund Activity: Q1 2018 in Review

2 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Bioverativ Inc. Common Stock (BIVV) for Q1 2018, worth a combined $27K — down 100% from $5.76B a quarter earlier.

Sellers outnumbered buyers: 449 funds closed out of BIVV and 1 opened new positions — a net loss of 448 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Archford Capital Strategies, opening a new position worth an estimated $2.28K. The largest seller was BlackRock, exiting entirely with an estimated $585M sold.

  • 2 institutional investors held Bioverativ Inc. Common Stock (BIVV) as of Q1 2018, down from 459 in Q4 2017.
  • Funds reported $27K of Bioverativ Inc. Common Stock stock for Q1 2018, down 100% quarter-over-quarter.
  • 1 fund opened new Bioverativ Inc. Common Stock positions in Q1 2018 and 449 closed out, a net change of -448 holders.
  • The largest Bioverativ Inc. Common Stock buyer in Q1 2018 was Archford Capital Strategies, an estimated $2.28K added.
  • The largest Bioverativ Inc. Common Stock seller in Q1 2018 was BlackRock, an estimated $585M sold.

Based on aggregated 13F filings for Q1 2018.